TELA Bio, Inc. Common Stock
$1.25
-$0.04 (-3.10%)
$1.17Day Range$1.33
Key Statistics
Market Cap
$58.23M
Shares Outstanding
45.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 8, 2019
Round Lot
100
Locale
US
Trading Data
Day Open
$1.31
Day High
$1.33
Day Low
$1.17
Volume
481.1K
VWAP
$1.25
Prev Close
$1.29
Transactions
--
Acc. Volume
--
About TELA Bio, Inc. Common Stock
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841218 employees1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355484-320-2930IPO Nov 8, 2019US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001561921
- Composite FIGI
- BBG004CH7Z50
- Share Class FIGI
- BBG004CH7Z69
- Ticker Root
- TELA
- SIC Code
- 3841
About TELA Bio, Inc. Common Stock (TELA) Stock
TELA Bio, Inc. Common Stock (TELA) closed the 2026-09-18 session at $1.25, down 3.10% versus the previous close (-0.04). The stock opened at $1.31 and traded between $1.17 and $1.33 during that session. Session trading volume was 481K shares. The volume-weighted average price (VWAP) is $1.25.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
TELA Bio, Inc. Common Stock has a market capitalization of $58.2 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. TELA is listed on the XNAS exchange. The company employs approximately 218 people. TELA Bio, Inc. Common Stock is headquartered in MALVERN, PA. The recorded listing date is 2019-11-08.
On this page you can find market TELA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.